RENEW Trademark

Trademark Overview

On Monday, April 20, 2009, a trademark application was filed for RENEW with the United States Patent and Trademark Office. The USPTO has given the RENEW trademark a serial number of 77717531. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, April 2, 2021. This trademark is owned by Celgene Corporation. The RENEW trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research, namely, conducting clinical trials on the safety and effectiveness of lenalidomide and conducting clinical trials in the field of hematology and oncology
renew

General Information

Serial Number77717531
Word MarkRENEW
Filing DateMonday, April 20, 2009
Status710 - CANCELLED - SECTION 8
Status DateFriday, April 2, 2021
Registration Number3842543
Registration DateTuesday, August 31, 2010
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 13, 2010

Trademark Statements

Goods and ServicesMedical and scientific research, namely, conducting clinical trials on the safety and effectiveness of lenalidomide and conducting clinical trials in the field of hematology and oncology

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, April 2, 2021
Primary Code042
First Use Anywhere DateSaturday, October 31, 2009
First Use In Commerce DateSaturday, October 31, 2009

Trademark Owner History

Party NameCelgene Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameCelgene Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameCelgene Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901

Trademark Events

Event DateEvent Description
Friday, April 2, 2021CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Saturday, August 31, 2019COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Saturday, April 16, 2016NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Saturday, April 16, 2016REGISTERED - SEC. 8 (6-YR) ACCEPTED
Saturday, April 16, 2016CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, March 28, 2016TEAS SECTION 8 RECEIVED
Monday, August 31, 2015COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, July 29, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 31, 2010REGISTERED-PRINCIPAL REGISTER
Tuesday, July 27, 2010NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, July 26, 2010LAW OFFICE REGISTRATION REVIEW COMPLETED
Monday, July 19, 2010ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, July 9, 2010STATEMENT OF USE PROCESSING COMPLETE
Tuesday, June 15, 2010USE AMENDMENT FILED
Thursday, July 8, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, June 15, 2010TEAS STATEMENT OF USE RECEIVED
Tuesday, June 8, 2010NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 13, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 13, 2010PUBLISHED FOR OPPOSITION
Friday, March 5, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, March 4, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 3, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 1, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 1, 2010TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Saturday, January 30, 2010NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Saturday, January 30, 2010INQUIRY TO SUSPENSION E-MAILED
Saturday, January 30, 2010SUSPENSION INQUIRY WRITTEN
Friday, January 22, 2010LIE CHECKED SUSP - TO ATTY FOR ACTION
Thursday, July 16, 2009NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, July 16, 2009LETTER OF SUSPENSION E-MAILED
Thursday, July 16, 2009SUSPENSION LETTER WRITTEN
Thursday, July 2, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 2, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 1, 2009TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 1, 2009COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED
Wednesday, July 1, 2009ASSIGNED TO LIE
Tuesday, June 30, 2009NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Tuesday, June 30, 2009EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Tuesday, June 30, 2009EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Tuesday, June 30, 2009ASSIGNED TO EXAMINER
Thursday, April 23, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, April 23, 2009NEW APPLICATION ENTERED IN TRAM

Related Keywords

renew clinical conducting trials lenalidomide field hematology oncology effectiveness safety research